In today’s recent session, 0.58 million shares of the Acadia Healthcare Company Inc (NASDAQ:ACHC) have been traded, and its beta is 1.17. Most recently the company’s share price was $29.86, and it changed around $1.05 or 3.64% from the last close, which brings the market valuation of the company to $2.77B. ACHC at last check was trading at a discount to its 52-week high of $82.40, offering almost -175.95% off that amount. The share price’s 52-week low was $27.61, which indicates that the recent value has risen by an impressive 7.54% since then. We note from Acadia Healthcare Company Inc’s average daily trading volume that its 10-day average is 1.69 million shares, with the 3-month average coming to 1.84 million.
Acadia Healthcare Company Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.46. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended ACHC as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight. Acadia Healthcare Company Inc is expected to report earnings per share of 0.36 for the current quarter.
Acadia Healthcare Company Inc (NASDAQ:ACHC) trade information
Instantly ACHC has been showing a green trend so far today with a performance of 3.64% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 30.23 on recent trading dayincreased the stock’s daily price by 1.22%. The company’s shares are currently down -24.69% year-to-date, but still up 2.05% over the last five days. On the other hand, Acadia Healthcare Company Inc (NASDAQ:ACHC) is -29.49% down in the 30-day period. We can see from the shorts that 6.52 million shares have been sold at a short interest cover period of 2.66 day(s).
The consensus price target as assigned by Wall Street analysts is $76, which translates to bulls needing to increase their stock price by 60.71% from its current value. Analyst projections state that ACHC is forecast to be at a low of $43 and a high of $87.
Acadia Healthcare Company Inc (ACHC) estimates and forecasts
The year-over-year growth rate is expected to be 5.83%, up from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 769.87M in revenue for the current quarter. 11 analysts expect Acadia Healthcare Company Inc to make 844.58M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 768.05M and 796.04M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 0.24%. Forecasts for the next quarter put sales growth at 6.10%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.49%. Acadia Healthcare Company Inc earnings are expected to increase by -16.67% in 2025, but the outlook is negative -1.36% per year for the next five years.
Acadia Healthcare Company Inc (NASDAQ:ACHC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.98% of Acadia Healthcare Company Inc shares, and 109.91% of them are in the hands of institutional investors. The stock currently has a share float of 113.29%. Acadia Healthcare Company Inc stock is held by 422.0 institutions, with WELLINGTON MANAGEMENT GROUP LLP being the largest institutional investor. By 2024-06-30, it held 11.3414% of the shares, which is about 10.39 million shares worth $701.87 million.
VANGUARD GROUP INC, with 9.7108% or 8.9 million shares worth $600.96 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Health Care Fund and iShares Core S&P Mid-Cap ETF were the top two Mutual Funds as of Oct 31, 2024. The former held 5.12 shares worth $153.39 million, making up 5.52% of all outstanding shares. On the other hand, iShares Core S&P Mid-Cap ETF held roughly 3.02 shares worth around $90.39 million, which represents about 3.25% of the total shares outstanding.
